CRP and anemia (phenotype): Systemic inflammatory markers, including anemia (49% of cases), elevated gamma globulins (45%), increased erythrocyte sedimentation rate (55%), and elevated C-reactive protein (75%), have been reported, suggesting an inflammatory response secondary to tumor presence [12,14].